Children and adolescents with diabetes using inhaled insulin had an increase in HbA1c from baseline to 1 year, according to data from the INHALE-1 extension trial published in Diabetes Technology & ...

Petrelintide achieved up to 10.7% mean body weight reduction at week 42 versus 1.7% with placebo (p-valueAt the maximally effective dose, there were no cases of vomiting and no treatment ...

Zealand Pharma’s Roche-partnered amylin analog demonstrated “placebo-like tolerability” and up to 10.7% mean weight loss at ...

Petrelintide achieved up to 10.7% mean body weight reduction at week 42 (versus 1.7% with placebo) and demonstrated placebo-like tolerability At the maximally effective dose, there were no cases of ...

Petrelintide achieved up to 10.7% mean body weight reduction at week 42 versus 1.7% with placebo (p-valueAt the maximally effective dose, there were no cases of vomiting and no treatment discontinuati ...